title: Withdrawal of Continuous Positive Airway Pressure Therapy for 2 Weeks in Obstructive Sleep Apnoea Patients Results in Increased Circulating Platelet and Leucocyte-Derived Microvesicles.
authors.affiliation: Department of Clinical and Laboratory Immunology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
authors.forename: Lisa
authors.initials: L
authors.lastname: Ayers
authors.forename: Chris
authors.initials: C
authors.lastname: Turnbull
authors.forename: Nayia
authors.initials: N
authors.lastname: Petousi
authors.forename: Berne
authors.initials: B
authors.lastname: Ferry
authors.forename: Malcolm
authors.initials: M
authors.lastname: Kohler
authors.forename: John
authors.initials: J
authors.lastname: Stradling
mesh_terms: D000368:Aged; D017304:Annexin A5 / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism*; D055252:Cell-Derived Microparticles / Q000378:metabolism*; D045422:Continuous Positive Airway Pressure; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D039661:Integrin beta3 / Q000378:metabolism; D017493:Leukocyte Common Antigens / Q000378:metabolism; D007962:Leukocytes / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D040201:Platelet Membrane Glycoprotein IIb / Q000378:metabolism; D020181:Sleep Apnea, Obstructive / Q000378:metabolism* / Q000628:therapy; D028761:Withholding Treatment
chemical_list: D017304:Annexin A5; D039661:Integrin beta3; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D040201:Platelet Membrane Glycoprotein IIb; D017493:Leukocyte Common Antigens